Clinical trial NCT05269459 - References

PTSD — Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults

Citation(s)

•   Andrewes DG, Jenkins LM
  The Role of the Amygdala and the Ventromedial Prefrontal Cortex in Emotional Regulation: Implications for Post-traumatic Stress Disorder. Neuropsychol Rev. 2019 Jun;29(2):220-243. doi: 10.1007/s11065-019-09398-4. Epub 2019 Mar 14.
•   Association, A
  P. (2013). Diagnostic and Statistical Manual 5. Washington D.C.: American Psychiatric Association.
•   Association, A
  P. (2017). Medications for PTSD. Retrieved from https://www.apa.org/ptsd-guideline/treatments/medications
•   Babson KA, Sottile J, Morabito D
  Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Curr Psychiatry Rep. 2017 Apr;19(4):23. doi: 10.1007/s11920-017-0775-9.
•   Elms L, Shannon S, Hughes S, Lewis N
  Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J Altern Complement Med. 2019 Apr;25(4):392-397. doi: 10.1089/acm.2018.0437. Epub 2018 Dec 13.
•   Elsaid S, Kloiber S, Le Foll B
  Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.
•   FDA
  (2017). Evaluating Drug Effects on the Ability to Operate a Motor Vehicle.
•   Hori H, Kim Y
  Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci. 2019 Apr;73(4):143-153. doi: 10.1111/pcn.12820. Epub 2019 Feb 21.
•   Hurd YL
  Leading the Next CBD Wave-Safety and Efficacy. JAMA Psychiatry. 2020 Apr 1;77(4):341-342. doi: 10.1001/jamapsychiatry.2019.4157. No abstract available.
•   Marx BP, Lee DJ, Norman SB, Bovin MJ, Sloan DM, Weathers FW, Keane TM, Schnurr PP
  Reliable and clinically significant change in the clinician-administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans. Psychol Assess. 2022 Feb;34(2):197-203. doi: 10.1037/pas0001098. Epub 2021 Dec 23.
•   Merickel J, High R, Smith L, Wichman C, Frankel E, Smits K, Drincic A, Desouza C, Gunaratne P, Ebe K, Rizzo M
  Driving Safety and Real-Time Glucose Monitoring in Insulin-Dependent Diabetes. Int J Automot Eng. 2019;10(1):34-40. doi: 10.20485/jsaeijae.10.1_34. Epub 2019 Feb 4.
•   Merickel, J
  , Robin, H., Smith, L., Wichman, C., Frankel, E., Smits, K., . . . Rizzo, M. (2017). At-risk driving behavior in drivers with diabetes: A neuroergonomics approach. Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 61(1), 1881-1885.
•   Sholler DJ, Schoene L, Spindle TR
  Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies. Curr Addict Rep. 2020 Sep;7(3):405-412. doi: 10.1007/s40429-020-00326-8. Epub 2020 Jul 25.
•   Stanciu CN, Brunette MF, Teja N, Budney AJ
  Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. Psychiatr Serv. 2021 Apr 1;72(4):429-436. doi: 10.1176/appi.ps.202000189. Epub 2021 Feb 3.
•   Wall MB, Pope R, Freeman TP, Kowalczyk OS, Demetriou L, Mokrysz C, Hindocha C, Lawn W, Bloomfield MA, Freeman AM, Feilding A, Nutt D, Curran HV
  Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. J Psychopharmacol. 2019 Jul;33(7):822-830. doi: 10.1177/0269881119841568. Epub 2019 Apr 23.

Safety and Efficacy of Cannabidiol (CBD) for Symptoms of Post-Traumatic Stress Disorder (PTSD) in Adults Using Liquid StructureTM Formulation (NantheiaTM ATL5).

Details for clinical trial NCT05269459